Skip to main content
  1. Drug Discovery
    • Drug Discovery
    Improving the efficiency of oligonucleotide synthesis and purification to ensure consistent access t ...
  2. CMC & Process Development
    • CMC & Process Development
    Defining acceptance criteria Over-designed oligonucleotide drugs - hurdles in upscaling and GMP anal ...
  3. Drug Discovery
    • CMC & Process Development
    What oligonucleotide chemistries are currently considered well-established to apply for N-of-1 treat ...

    ChemGenes

  4. Drug Delivery
    • Drug Delivery
    Enhancing efficacy and stability with novel oligonucleotide modifications and chemistries Beyond tar ...
  5. New Modalities
    • New Modalities
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    Afternoon Refreshments
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    Networking Lunch
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    Evening Drinks Reception
  6. CMC & Process Development
    • CMC & Process Development
    With the emergence the last decade of novel powerful gene editing tools such as CRISPR-Cas9 and ADAR ...

    ChemGenes

    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    Spotlight Presentation: CMC Framework for Oligonucleotide Development
    Definition of CMC framework for therapeutic oligonucleotides. Phase-appropriate overview of the CMC ...
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    1-2-1 Meetings/Networking Break
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    1-2-1 Meetings/Networking Break
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    Opening Address & Keynote Presentation: Nucleic acid conjugates: from supramolecular systems to therapeutic applications
    Amphiphilic biomolecules are emerging as promising supramolecular materials for biomedical and techn ...
  7. CMC & Process Development
    • CMC & Process Development
    What are the primary molecular interactions driving aggregate formation during peptide purification? ...

    PolyPeptide Group

    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    Morning Refreshments
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    1-2-1 Meetings/Networking Break
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    1-2-1 Meetings/Networking Break
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    Registration
  8. CMC & Process Development
    • CMC & Process Development
    Optimizing delivery systems for RNA therapeutics to improve targeting, uptake, and bioavailability i ...
  9. Drug Delivery
    • Drug Delivery
    Discussion Points:   1. Strategies for Enhancing Targeted Delivery with Next-Generation LNPs What ad ...